Financials
- Market Capitalization 396.18 M
- Employee 75
- Founded 2021
- CEO N/A
- Website www.upstreambio.com
- Headquarter Delaware, United States
- FIGI BBG017Y2X923
- Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.21
Rapporto prezzo/fatturato
512.3
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2840 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.44 USD | -1.32% | -14.14% | +9.66% | -38.77% | 565.21 M USD | ||
| 3024 | CBIO Crescent Biopharma, Inc. - Common Stock | 15.69 USD | -9.52% | -7.16% | -12.00% | +22.58% | 432.60 M USD | ||
| 3175 | QTTB Q32 Bio Inc. - Common Stock | 21.38 USD | +90.72% | +65.48% | +67.29% | +953.20% | 362.53 M USD | ||
| 3324 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.70 USD | -1.21% | -7.72% | -3.92% | -5.53% | 308.25 M USD |